Author: Extroverting

Read More

Tara Mind attracts $8M to bring ketamine therapy to workplace benefits

Tara Mind secured $8 million in funding to expand access to ketamine-assisted therapy for employees, as part of their health benefits. The funding round was led by private equity firm Satori Neuro, with notable contributions from Echo Investment Capital, Crumpton Ventures, Empath Ventures, and entrepreneur Blake Mykoskie, founder of TOMS. …

Read More

EU awards €6.5 million for psychedelic drug trial

The European Union awarded €6.5 million to PsyPal, a consortium of 19 partners from nine different European countries, for a study on the psychedelic compound psilocybin. PsyPal includes: Psychiatrists Palliative care physicians Psychologists Experts in psilocybin therapy Researchers focusing on spiritual care Representatives from religious institutions The trial …